Physiomics Share Price (PYC)

3.85 +0.05 (+1.32%) delayed: 3:25PM BST
Bid price 3.80 Open price 3.73
Ask price 3.90 Prev close 3.80
High price 3.87 Spread 2.56%
Low price 3.73 Volume 267,395

Register now for FREE live Physiomics share prices, Physiomics stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Physiomics Level 2 Data, indepth research tools and investor commentary for Physiomics (PYC) and other London Stock Exchange equities.

Physiomics Share Price Chart

Advanced Charts >>

Register now for FREE Physiomics share price charts

Physiomics Share Price Information

Name Physiomics Epic PYC
Sector Health Care Equipment & Services ISIN GB00BDR6W943
Activites Physiomics plc is a solutions provider to the R&D based pharmaceutical and biotechnology industry with a focus on oncology. The Company's Virtual Tumour technology uses computer modelling to predict the effects of cancer drugs and treatments to improve the success rate of drug discovery and development projects while reducing time and cost. The predictive capability of Virtual Tumour has been confirmed by 55 projects, involving over 25 targets and 60 drugs, and has worked with clients such as Merck KGaA, Merck & Co, Bayer and Lilly. Based in Oxford UK, the Company works with clients worldwide to support their pre-clinical and clinical oncology development programs. Its team of scientists and computer modelling experts provide bespoke solutions encompassing data, analytics and insight. Index n/a

Physiomics Key Numbers

Latest Share Price (p) 3.85 Net Gearing (%) -29.64
Market Capitalisation (£m) 2.73 Gross Gearing (%) 20.96
Shares in issue (m) 71.91 Debt Ratio 0.00
P/E Ratio -4.87 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.27
Dividend Yield (%) 0.00 Price to book value 8.27
Dividend cover (x) 0.00 ROCE (%) -160.61
Earning per share (p) -0.78 EPS Growth (%) -7,700.00
52 week high / low 32.00 / 0.93 DPS Growth (%) n/a

Physiomics Director Deals

Dec.Date Type Director Pos No. of Shares
12/12/2017 SELL Dr Jim Millen CEO 240,000
12/12/2017 SELL Dr Christophe Chassagnole ED 600,000
22/12/2016 BUY Dr Jim Millen CEO 200,000
21/05/2012 BUY Dr Mark Chadwick RES 3,970,151
21/05/2012 BUY Dr Christophe Chassagnole ED 3,000,000

More Physiomics Director Deals >>

Physiomics Company News

07:00 09/08/2018

Contract award

RNS Number : 3060X Physiomics PLC 09 August 2018   Physiomics plc ("Physiomics") or ("the Company")     Contract award   Physiomics signs agreement with new European biotech client   Physiomics plc (AIM: PYC), a provider of technology-based...

More Physiomics Company News >>

Register now for FREE Physiomics company news

Physiomics Share Price Discussions

more than 1 year ago

Physiomics (PYC)

I wonder if somebody has found more than one bunsen burner which PYC own at the car boot - thought about selling them at a great loss this afternoon and then wow. Might not continue but would be nice if whoever was as stupid as I was at the time of my purchase could make a little profit. India...

more than 1 year ago

PYC (PYC)

Bought when floated. Downhill all the way since then. Should I stay or should I go?

Register now for FREE Physiomics share price discussions